Rhythm Pharmaceuticals Inc header image

Rhythm Pharmaceuticals Inc

RYTM

Equity

ISIN null / Valor 25337263

NASDAQ (2026-04-06)

USD 86.96+0.78%

Rhythm Pharmaceuticals Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Rhythm Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare genetic disorders of obesity, specifically those related to the melanocortin-4 receptor (MC4R) pathway. These disorders are distinct from general obesity and are characterized by early-onset, severe obesity and hyperphagia, a condition marked by an insatiable hunger. The company's primary focus is on addressing these rare MC4R pathway impairments to provide targeted therapeutic solutions for patients suffering from these debilitating conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

85.2%1Y

386%3Y

317%5Y

Performance

56.4%1Y

55.3%3Y

74.2%5Y

Volatility

5938 M

Market cap (USD)

535,141

Daily traded volume (Shares)

56.78 / 55.07

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

4.00

Innovation:

5.00

Society:

5.00

Nature:

2.00

Adrian Pusz

Switzerland, 20 Apr 2025

Rhythm develops what will always be needed - rare disease therapies

EQUITIES OF THE SAME SECTOR

M1 Kliniken AG

M1 Kliniken AG Valor: 29694419

Annual Return

-50%0%+50%

Risk level

110

2.29%EUR 15.18

CorVel Corp

CorVel Corp Valor: 921843

Annual Return

-50%0%+50%

Risk level

110

-0.73%USD 54.06

Ypsomed Holding AG

Ypsomed Holding AG Valor: 1939699

Annual Return

-50%0%+50%

Risk level

110

-0.36%CHF 279.50

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA Valor: 332902

Annual Return

-50%0%+50%

Risk level

110

-0.84%EUR 43.58

PTC Therapeutics Inc

PTC Therapeutics Inc Valor: 2515234

Annual Return

-50%0%+50%

Risk level

110

1.67%USD 68.90

Hims & Hers Health Inc

Hims & Hers Health Inc Valor: 59397181

Annual Return

-50%0%+50%

Risk level

110

6.22%USD 20.33

Dr Reddy'S Laboratories Ltd

Dr Reddy'S Laboratories Ltd Valor: 1221723

Annual Return

-50%0%+50%

Risk level

110

-1.35%USD 13.14

Biogaia AB

Biogaia AB Valor: 118922125

Annual Return

-50%0%+50%

Risk level

110

-4.02%SEK 116.90

Medartis Holding AG

Medartis Holding AG Valor: 38620023

Annual Return

-50%0%+50%

Risk level

110

1.49%CHF 81.60

Basilea Pharmaceutica Ltd, Allschwil

Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244

Annual Return

-50%0%+50%

Risk level

110

0.73%CHF 55.10

SIX

FactSet

Clearbit

Logos provided by Clearbit